610 filings
15-12G
BLPH
Bellerophon Therapeutics, Inc.
5 Mar 24
Securities registration termination
8:16pm
8-K
BLPH
Bellerophon Therapeutics, Inc.
4 Mar 24
Departure of Directors or Certain Officers
5:25pm
SC 13G/A
BLPH
Bellerophon Therapeutics, Inc.
14 Feb 24
Bellerophon Therapeutics / PERCEPTIVE ADVISORS ownership change
4:50pm
SC 13G/A
Tang Capital Partners LP
14 Feb 24
Bellerophon Therapeutics / TANG CAPITAL PARTNERS ownership change
4:00pm
DEFA14A
BLPH
Bellerophon Therapeutics, Inc.
12 Feb 24
Additional proxy soliciting materials
3:44pm
DEFA14A
BLPH
Bellerophon Therapeutics, Inc.
12 Feb 24
Additional proxy soliciting materials
12:39pm
8-K
BLPH
Bellerophon Therapeutics, Inc.
30 Jan 24
Entry into a Material Definitive Agreement
9:29am
SC 13G
BLPH
Bellerophon Therapeutics, Inc.
26 Jan 24
Bellerophon Therapeutics / Lepercq De Neuflize Asset Management ownership change
10:46am
8-K
BLPH
Bellerophon Therapeutics, Inc.
22 Jan 24
Submission of Matters to a Vote of Security Holders
3:21pm
8-K
BLPH
Bellerophon Therapeutics, Inc.
10 Jan 24
Submission of Matters to a Vote of Security Holders
4:05pm
DEFA14A
BLPH
Bellerophon Therapeutics, Inc.
3 Jan 24
Additional proxy soliciting materials
1:49pm
25-NSE
The Nasdaq Stock Market LLC
27 Dec 23
Exchange delisting
9:01am
8-K
BLPH
Bellerophon Therapeutics, Inc.
12 Dec 23
Submission of Matters to a Vote of Security Holders
4:10pm
8-K
BLPH
Bellerophon Therapeutics, Inc.
21 Nov 23
Departure of Directors or Certain Officers
12:00am
10-Q
2023 Q3
BLPH
Bellerophon Therapeutics, Inc.
Quarterly report
14 Nov 23
4:31pm
DEF 14A
BLPH
Bellerophon Therapeutics, Inc.
Definitive proxy
6 Nov 23
4:30pm
PRE 14A
BLPH
Bellerophon Therapeutics, Inc.
Preliminary proxy
27 Oct 23
10:50am
SC 13D/A
Puissance Life Science Opportunities Fund VI
17 Oct 23
Bellerophon Therapeutics / Puissance Life Science Opportunities Fund VI ownership change
9:05pm
SC 13D/A
Puissance Life Science Opportunities Fund VI
16 Oct 23
Bellerophon Therapeutics / Puissance Life Science Opportunities Fund VI ownership change
8:56pm
4
Puissance Life Science Opportunities Fund VI
16 Oct 23
Bellerophon Therapeutics / Theodore T Wang ownership change
8:51pm